logo
BA
Biren Amin
Analyst at Jefferies
USA
Ticker Coverage
ALKS
Sector Coverage
Mentions in the News
Novartis takes on Regeneron, Roche blockbusters with Beovu approval
Novartis has its next big drug approval. The FDA on Tuesday approved wet AMD drug Beovu, which will go up against entrenched blockbusters Eylea from Regeneron and Lucentis from Roche. The drug has shown it can match up against Eylea's efficacy and bested the …
Published: Oct 8 2019
Earnings Call Transcripts
Minerva Neurosciences Inc (NERV) Q3 2019 Earnings Call Transcript
NERV earnings call for the period ending October 1, 2019.
Published: Oct 1 2019
Would you like to be included in the directory? Let us know!
exchange@streetcontxt.com
© Street Contxt. All Rights Reserved.
Privacy